Memphis Pharmaceutical’s capital increase subscription covered by 93.78% in 1st phase

Updated 9/9/2024 10:56:00 AM
Memphis Pharmaceutical’s capital increase subscription covered by 93.78% in 1st phase

Arab Finance: Memphis Pharmaceutical and Chemical Industries’ first phase of capital increase subscription has been covered by 93.78% at a total value of EGP 160.601 million, as per a disclosure.

Accordingly, 16.06 million shares were covered, with the remaining uncovered shares amounting to 1.065 million.

On August 7th, The Egyptian Exchange’s (EGX) listing committee approved listing an increase of EGP 171.25 million for Memphis Pharmaceutical and Chemical Industries.

Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940.

 

 

 

 

 

 

 

Related News